Semaglutide vs. Ozempic vs. Wegovy vs. Mounjaro: What’s the Difference?
The use of injectable drugs to treat obesity has drawn more attention in recent years. When paired with a lower calorie diet and more exercise, the medications semaglutide, ozempic, wegovy, and mounjaro are used to treat obesity. Despite their obvious similarities, these injectable drugs differ in a few significant ways. Continue reading to find out the similarities and differences between these drugs and how they function. Visit Dr. Shadi Kranitz, MD, for an effective weight-loss program. We are conveniently located at 20469 Yorba Linda Blvd CA 92886, Located in East Village Shopping Center inside Sola Salon Studios, Suite #7. For more information, please contact us or schedule an appointment online.
Table of Contents:
What is the difference between Semaglutide, Ozempic, Wegovy, and Mounjaro?
What are Semaglutide, Mounjaro, Wegovy, and Ozempic approved for?
Which one do we choose?
Do Semaglutide, Mounjaro, Wegovy, and Ozempic help keep weight off long term?
There are differences between these medications, with the key distinction being which active ingredient they contain. Both Ozempic and Wegovy are brand names for medications containing semaglutide as the active ingredient. Semaglutide can also be prescribed as a generic drug instead of a brand-name version of the medication. On the other hand, Mounjaro is a brand-name medication that contains tirzepatide as its active ingredient.
While the action of all of these medications is quite similar, Mounjaro offers a unique advantage, as tirzepatide acts on two gut hormones. This is different from semaglutide-based medications, which only affect one hormone. Ozempic, Wegovy, and Mounjaro all affect the brain to promote feelings of fullness and influence eating decisions. This is what makes these medications so effective in weight and related condition management.
The FDA has approved both Ozempic and Mounjaro as treatments for type 2 diabetes. While Ozempic can occasionally be prescribed for off-label use to individuals who are obese or overweight with certain medical conditions, such as high blood pressure, its primary use is to regulate glucose levels by stimulating insulin production. In addition, the FDA acknowledges that prescribing Ozempic can reduce the risk of serious cardiovascular events in individuals with type 2 diabetes and heart disease.
Mounjaro is the first medication to target two gut hormones simultaneously to increase insulin sensitivity, decrease appetite, and slow the digestive system. While Mounjaro is FDA-approved for type 2 diabetes treatment, its active ingredient is approved for weight loss under a different brand name, Zepbound.
On the other hand, Wegovy is FDA-approved to support long-term weight loss and management. To qualify for Wegovy treatment, a patient should fall into one of these categories:
• A body mass index (BMI) of 30 or higher.
• A BMI of 27 or higher with at least one weight-related health condition, such as type 2 diabetes, high cholesterol, or heart disease.
To determine which medication to prescribe to you, your healthcare professional will thoroughly evaluate your medical history as well as break down the benefits and risks of each option during your consultation session. The doctor will carefully consider your needs before making the decision. If the main concerns revolve around your body’s blood sugar regulation or insulin production, Mounjaro or Ozempic will most likely be prescribed.
In contrast, if you have tried diligently to shed excess weight but have not found success with first-line approaches, such as dieting and increasing exercise, the doctor may recommend Wegovy. Regardless of which specific medication is selected, the healthcare professional will develop a carefully crafted treatment plan to ensure you have structured support to achieve your goals and feel healthier.
It’s crucial to adhere to the recommendations provided by your healthcare professionals to unlock the most significant improvements through your treatment. By staying consistent, eating well, hydrating properly, getting enough rest, and exercising regularly, you can enjoy a transformation in both your physical and mental wellness.
Semaglutide, Wegovy, Ozempic, and Mounjaro can offer a powerful boost to your weight loss journey. Many people wonder whether the incredible results will last in the long term. The good news is that they can! These medications have been found to facilitate an average weight reduction of 15% to 20% of the starting weight throughout treatment.
It’s important to keep in mind that after stopping your treatment, you may gain some of the weight back. This is especially likely if you do not stick to the healthy lifestyle choices that you adopted throughout your treatment. As you transition off weight loss medication, it’s crucial to get enough sleep, moderate your carbohydrates, and find time to get active. With consistency, you can continue to enjoy the benefits you achieved with weight loss medication for a long time after your treatment! At Dr. Shadi Concierge Med Spa, we offer customized weight loss plans. We are conveniently located at 20469 Yorba Linda Blvd CA 92886, Located in East Village Shopping Center inside Sola Salon Studios, Suite #7. For more information, please contact us or schedule an appointment online. We serve clients from Yorba Linda CA, Anaheim Hills CA, Placentia CA, Olive CA, Orange CA, Fullerton CA, Brea CA, and surrounding areas.